venBio Partners LLC Long-Term Concentrated

CIK: 0001776382 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value ($000): $451,083 (100.0% shares, 0.0% debt)

Holdings (10)

ALXO ALX ONCOLOGY HLDGS INC 36.3%

Value ($000) $163,929 Shares 9,699,925 Est. Cost $39.31 Unrealized -56.6%

HRMY HARMONY BIOSCIENCES HLDGS IN 16.7%

Value ($000) $75,139 Shares 1,544,484 Est. Cost $36.46 Unrealized +11.9%

VTYX VENTYX BIOSCIENCES INC 15.1%

Value ($000) $68,007 Shares 5,011,536 Est. Cost $18.95 Unrealized -29.5%

PHVS PHARVARIS N V 9.3%

Value ($000) $41,771 Shares 2,303,310 Est. Cost $31.46 Unrealized -44.1%

— CINCOR PHARMA INC 7.7%

Value ($000) $34,742 Shares 1,980,706 Est. Cost $17.54 Unrealized —

— AKERO THERAPEUTICS INC 6.8%

Value ($000) $30,816 Shares 2,171,664 Est. Cost $19.15 Unrealized —

— IMPEL NEUROPHARMA INC 3.9%

Value ($000) $17,580 Shares 2,759,791 Est. Cost $8.85 Unrealized —

— CHECKMATE PHARMACEUTICALS IN 2.6%

Value ($000) $11,718 Shares 3,673,374 Est. Cost $11.51 Unrealized —

— ELEVATION ONCOLOGY INC 1.5%

Value ($000) $6,573 Shares 2,608,167 Est. Cost $13.57 Unrealized —

— VERONA PHARMA PLC 0.2%

Value ($000) $808 Shares 161,897 Est. Cost $9.65 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALXO	ALX ONCOLOGY HLDGS INC	9,699,925	$163,929	36.3%	$39.31	-56.6%	COM	00166B105
HRMY	HARMONY BIOSCIENCES HLDGS IN	1,544,484	$75,139	16.7%	$36.46	+11.9%	COM	413197104
VTYX	VENTYX BIOSCIENCES INC	5,011,536	$68,007	15.1%	$18.95	-29.5%	COM	92332V107
PHVS	PHARVARIS N V	2,303,310	$41,771	9.3%	$31.46	-44.1%	COM	N69605108
—	CINCOR PHARMA INC	1,980,706	$34,742	7.7%	$17.54	—	COM	17240Y109
—	AKERO THERAPEUTICS INC	2,171,664	$30,816	6.8%	$19.15	—	COM	00973Y108
—	IMPEL NEUROPHARMA INC	2,759,791	$17,580	3.9%	$8.85	—	COM	45258K109
—	CHECKMATE PHARMACEUTICALS IN	3,673,374	$11,718	2.6%	$11.51	—	COM	162818108
—	ELEVATION ONCOLOGY INC	2,608,167	$6,573	1.5%	$13.57	—	COM	28623U101
—	VERONA PHARMA PLC	161,897	$808	0.2%	$9.65	—	SPONSORED ADS	925050106